ArticleScience advances2026
Structural basis of kinesin-1 autoinhibition and its control of microtubule-based motility.
Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
6 authors.
Funding
Abstract
Kinesin-1 was the first microtubule motor identified, responsible for anterograde transport of diverse cargo in eukaryotic cells. Defects or misregulation of kinesin-1 is linked to multiple neurological disorders, and various pathogens exploit kinesin-1 to transport their cargo. In the absence of cargo, kinesin-1 adopts a compact autoinhibited conformation to enable its spatiotemporal regulation and prevent futile energy consumption. Despite its importance, the structural mechanisms for kinesin-1 autoinhibition and activation remain poorly understood. Here, we report the cryo-electron microscopy structure of the autoinhibited kinesin-1 heterotetramer and validate it using cross-linking mass spectrometry. The structure reveals a 36-nanometer particle in which the kinesin heavy chains (KHCs) adopt a head-to-tail configuration, stabilized by asymmetrically arranged kinesin light chain (KLC) tetratricopeptide repeat (TPR) domains that bind across folded KHC coiled coils and in between the KHC motor domains. This architecture inhibits kinesin motility by constraining the dimeric motor domains in a configuration that is incompatible with processive motility. In addition, the structure shows that the KLC carboxyl-terminal helices occlude the TPR cargo-binding interfaces, revealing a second layer of autoinhibition that directly blocks cargo engagement. Functional studies and structural modeling suggest that binding of regulatory factors, such as MAP7D3, competes with intramolecular KHC coiled-coil interactions, resulting in the unfurling of the autoinhibited structure and activating motor motility. These findings provide a molecular framework for understanding kinesin-1 regulation and its implications for intracellular transport.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.